Trial Profile
A Double-blind, Randomized, Placebo Controlled Single and Multiple Dose Study to Assess the Safety and Pharmacokinetics of Sodium Oligo-mannurarate (GV-971) Capsule in Healthy Chinese Subjects
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 06 Oct 2020
Price :
$35
*
At a glance
- Drugs Sodium oligomannurarate (Primary)
- Indications Alzheimer's disease
- Focus Pharmacokinetics
- Sponsors Shanghai Green Valley Pharmaceutical
- 26 Oct 2018 New trial record